EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+0.43%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$3.29B
AUM Growth
+$3.29B
(-3%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
70.15%
Holding
84
New
9
Increased
10
Reduced
4
Closed
18
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$63.3M |
| 2 |
Zymeworks
ZYME
|
$59.5M |
| 3 |
Adicet Bio
ACET
|
$31.8M |
| 4 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$29.6M |
| 5 |
Dyne Therapeutics
DYN
|
$26.9M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$70.9M |
| 2 |
Gossamer Bio
GOSS
|
$49.8M |
| 3 |
Avidity Biosciences
RNA
|
$47.3M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$39.1M |
| 5 |
Design Therapeutics
DSGN
|
$16.8M |
Sector Composition
| 1 | Healthcare | 99.78% |
| 2 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Avidity Biosciences
RNA
$6.12B
| – | – |
-2,899,285
| Closed | -$47.3M |
|
|
KNTE
77
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| – | – |
-175,000
| Closed | -$2.09M |
|
|
MRTX
78
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-1,015,572
| Closed | -$70.9M |
|
|
SGEN
79
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-285,793
| Closed | -$39.1M |
|
|
RETA
80
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| – | – |
-38,467
| Closed | -$967K |
|
|
OMEG
81
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
| – | – |
-50,000
| Closed | -$497K |
|
|
AKUS
82
DELISTED
Akouos, Inc. Common Stock
AKUS
| – | – |
-1,975,984
| Closed | -$13.4M |
|
|
JYAC
83
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| – | – |
-500,000
| Closed | -$4.99M |
|
|
FLAC
84
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
| – | – |
-487,615
| Closed | -$4.86M |
|